Verdict · sk:hormonal

Is Pycnogenol worth it?

SKIP IT

Pycnogenol is a branded maritime pine bark extract with scattered small studies, not a proven hormone supplement. The Cochrane verdict across chronic conditions is basically that the evidence is not strong enough, so hormone, menopause, fertility, and circulation bundles should not get a pass.

The call

Pycnogenol is standardized French maritime pine bark extract rich in procyanidins, but product identity does not solve evidence quality. The updated Cochrane review of pine bark extract across chronic disorders did not find sufficient evidence to support efficacy for the reviewed conditions. Hormonal claims are even less secure because they usually rely on adjacent endpoints, small branded studies, or mechanistic antioxidant language. The practical verdict is to skip unless a clinician is using it for a specific monitored reason.

Safety

Pycnogenol can cause gastrointestinal upset, headache, dizziness, mouth ulcers, rash, or allergy. Use caution with anticoagulants, antiplatelet drugs, NSAIDs, diabetes medications, blood-pressure medications, immunosuppressants, autoimmune disease, bleeding disorders, or upcoming surgery. Avoid during pregnancy and lactation unless clinician-directed because safety evidence is limited. Stop for unusual bruising, bleeding, allergic symptoms, severe dizziness, or persistent gastrointestinal pain.

Dose that matters: No hormone-support dose is established. Studies of maritime pine bark extracts often use roughly 50-200 mg/day depending on the condition and product, but that does not justify buying it for hormonal balance. If used despite the skip verdict, choose a third-party-tested product and trial only one change at a time.

Sources

Tier 1 · evidence synthesis · Reviewed by the Stack-kit desk

Audit your whole shelf →   See all verdicts →

Goals